fosinopril has been researched along with Disease Models, Animal in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Ivkin, D; Karpov, A; Kaschina, E; Krasnova, M; Kulikov, A; Okovityi, S; Smirnov, A | 1 |
| Deng, ZJ; Fu, YH; Guo, JW; Li, LM; Liu, RX; Pan, JQ; Qiu, GQ; Yang, M | 1 |
| Cao, YX; Li, J; Wang, D; Yang, XM; Zhou, P | 1 |
| Du, SM; Gao, S; Guo, YW; Huang, LL; Wang, XH; Yu, TT | 1 |
| Burrell, LM; Cooper, ME; Jaworski, K; Kubota, E; Mifsud, SA; Wilkinson-Berka, JL | 1 |
| Abdel-Salam, OM; Arbid, MS; el-Batran, SA; el-Shenawy, SM; Nofal, SM | 1 |
| Chen, JL; Chen, ZJ; Gao, RL; Jing, ZC; Meng, L; Tian, Y; Wu, YJ; Yang, WX; Yang, YJ; You, SJ; Zhao, JL | 1 |
| Abdallah, HM; El-Batran, SA; El-Demerdash, E; Salam, OM; Shaffie, NM | 1 |
| Aberg, G; Beyer, S; Kowala, MC; Recce, R | 1 |
| Beschi, M; Bettoni, G; Böhm, M; Castellano, M; Cinelli, A; Porteri, E; Rizzoni, D; Rosei, EA | 1 |
| Bonnet, F; Burrell, LM; Cao, Z; Cooper, ME; Gilbert, RE; Tikkanen, I | 1 |
| Beck, L; Blanc-Guillemaud, V; Cherif, OK; Davy, JM; Jover, B | 1 |
| Liang, X; Su, M; Xie, X; Yu, G; Zhao, S | 1 |
13 other study(ies) available for fosinopril and Disease Models, Animal
| Article | Year |
|---|---|
Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats.
Topics: Animals; Benzhydryl Compounds; Bisoprolol; Cardiovascular Agents; Chronic Disease; Disease Models, Animal; Exercise Tolerance; Fosinopril; Glucosides; Heart Failure; Male; Myocardial Infarction; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors; Spironolactone; Ventricular Dysfunction, Left; Ventricular Function, Left | 2020 |
[Effects of Panax notoginseng saponins on ACE2 and TNF-alpha in rats with post-myocardial infarction-ventricular remodeling].
Topics: Angiotensin-Converting Enzyme 2; Animals; Antioxidants; Disease Models, Animal; Female; Fosinopril; Glutathione Peroxidase; Male; Malondialdehyde; Myocardial Infarction; Myocardium; Nitric Oxide; Panax notoginseng; Peptidyl-Dipeptidase A; Random Allocation; Rats; Rats, Sprague-Dawley; Saponins; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2010 |
[Effect of Astragalus and Salvia's effective components and their compatibility on JAK/STAT pathway].
Topics: Animals; Astragalus Plant; beta 2-Microglobulin; Disease Models, Animal; Drugs, Chinese Herbal; Fibrosis; Fosinopril; Janus Kinases; Kidney; Kidney Tubules; Random Allocation; Rats; Rats, Sprague-Dawley; Salvia; Saponins; Signal Transduction; STAT Transcription Factors; Ureteral Obstruction | 2011 |
[Effects of Xinjierkang on two kidney one clip-induced hypertension and target organ injury in rats].
Topics: Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Drug Combinations; Drugs, Chinese Herbal; Fosinopril; Heart Rate; Hypertension, Renal; Kidney Glomerulus; Male; Myocardium; Plants, Medicinal; Random Allocation; Rats; Rats, Sprague-Dawley; Renal Artery; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2012 |
Cardiorenal protective effects of vasopeptidase inhibition with omapatrilat in hypertensive transgenic (mREN-2)27 rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Body Weight; Cardiomegaly; Disease Models, Animal; Dose-Response Relationship, Drug; Fosinopril; Hypertension; Kidney; Male; Models, Cardiovascular; Neprilysin; Pyridines; Rats; Renin; Statistics as Topic; Survival Analysis; Systole; Thiazepines; Time Factors; Treatment Outcome | 2004 |
Studies on the glycemic and lipidemic effect of monopril and losartan in normal and diabetic rats.
Topics: Alloxan; Animals; Blood Glucose; Blood Proteins; Carbamates; Cholesterol, LDL; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Therapy, Combination; Egypt; Fosinopril; Gliclazide; Hyperlipidemias; Hypolipidemic Agents; Lipids; Losartan; Male; Piperidines; Rats; Rats, Sprague-Dawley; Triglycerides | 2004 |
[Beneficial effects of fosinopril on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion].
Topics: Animals; Blood Flow Velocity; Disease Models, Animal; Female; Fosinopril; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Swine; Swine, Miniature | 2005 |
Inhibition of the renin-angiotensin system attenuates the development of liver fibrosis and oxidative stress in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Carbon Tetrachloride; Disease Models, Animal; Dose-Response Relationship, Drug; Fosinopril; Glutathione; Hydroxyproline; Lipid Peroxidation; Lisinopril; Liver; Liver Cirrhosis; Liver Function Tests; Losartan; Male; Oxidative Stress; Rats; Renin-Angiotensin System | 2008 |
Regression of early atherosclerosis in hyperlipidemic hamsters induced by fosinopril and captopril.
Topics: Analysis of Variance; Animals; Aorta, Thoracic; Arteriosclerosis; Blood Pressure; Captopril; Cell Count; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cricetinae; Diet, Atherogenic; Disease Models, Animal; Foam Cells; Fosinopril; Heart Rate; Hyperlipidemias; Image Processing, Computer-Assisted; Macrophages; Male | 1995 |
Chronic ACE-inhibitor treatment and adrenergic mechanisms in spontaneously hypertensive rats.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Fosinopril; Hypertension; Mesenteric Arteries; Myocardium; Norepinephrine; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Ribonucleases; RNA, Messenger; Synaptic Transmission; Vascular Resistance | 1995 |
Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Autoradiography; Blood Pressure; Creatinine; Disease Models, Animal; Fosinopril; Glomerular Filtration Rate; Heart Failure; Hypertension, Renal; Kidney; Male; Nephrectomy; Neprilysin; Organ Size; Peptidyl-Dipeptidase A; Proteinuria; Pyridines; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Renin; Thiazepines; Urea | 2001 |
Effects of spironolactone and fosinopril on the spontaneous and chronic ventricular arrhythmias in a rat model of myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Chronic Disease; Disease Models, Animal; Electrocardiography, Ambulatory; Fosinopril; Heart Rate; Heart Ventricles; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Random Allocation; Rats; Rats, Wistar; Spironolactone; Time Factors; Ventricular Dysfunction; Ventricular Premature Complexes | 2001 |
Diverse effects of chronic treatment with losartan, fosinopril, and amlodipine on apoptosis, angiotensin II in the left ventricle of hypertensive rats.
Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apoptosis; Blood Pressure; China; Disease Models, Animal; Fosinopril; Heart Ventricles; Hypertrophy, Left Ventricular; Losartan; Models, Cardiovascular; Myocardium; Random Allocation; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1 | 2001 |